Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein

Cancer Research

Volumn 57, Issue 16, 1997, Pages 3365-3369

  Calmels, Sylvie ^a   Hainaut, Pierre ^a   Ohshima, Hiroshi ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PROTEIN P53; S NITROSOGLUTATHIONE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; DNA BINDING; DNA DAMAGE; DNA STRAND BREAKAGE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION;

BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; GLUTATHIONE; HUMANS; LIVER NEOPLASMS; NITRIC OXIDE; NITROSO COMPOUNDS; PENICILLAMINE; S-NITROSO-N-ACETYLPENICILLAMINE; S-NITROSOGLUTATHIONE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030808955     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ohshima, H., and Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res., 305: 253-264, 1994.
2. Nathan, C., and Xie, Q. W. Nitric oxide synthases: roles, tolls, and controls. Cell, 78: 915-918, 1994.
3. Stamler, J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell, 78: 931-936, 1994.
4. Thomsen, L. L., Lawton, F. G., Knowles, R. G., Beesley, J. E., Riveros Moreno, V., and Moncada, S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54: 1352-1354, 1994.
5. Ohshima, H., Brouet, I., Bandaletova, T. Y., Bartsch, H., Bancel, B., and Habib, N. A. Increased nitric oxide production in patients with liver cirrhosis. In: S. Moncada, M. Feelisch, R. Busse, and E. A. Higgs (eds.), The Biology of Nitric Oxide. Physiology and Clinical Aspects, pp. 521-524. London: Portland Press, 1994.
6. Jenkins, D. C., Charles, I. G., Baylis, S. A., Lelchuk, R., Radomski, M. W., and Moncada, S. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br. J. Cancer,70: 847-849, 1994.
7. Nguyen, T., Brunson, D., Crespi, C. L., Penman, B. W., Wishnok, J. S., and Tannenbaum, S. R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA, 89: 3030-3034, 1992.
8. Henry, Y., Lepoivre, M., Drapier, J. C., Ducrocq, C., Boucher, J. L., and Guissani, A. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J., 7: 1124-1134, 1993.
9. Kastan, M. B., Zhan, Q., el Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
10. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
11. Cho, Y., Gorina, S., Jeffrey, P. D., and Pavletich, N. P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science (Washington DC), 265: 346-355, 1994.
12. Bargonetti, J., Friedman, P. N., Kern, S. E., Vogelstein, B., and Prives, C. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell, 65: 1083-1091, 1991.
13. Hainaut, P., and Milner, J. A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Res., 53: 1739-1742, 1993.
14. Hainaut, P., Rolley, N., Davies, M., and Milner, J. Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. Oncogene, 10: 27-32, 1995.
15. Milner, J., Medcalf, E. A., and Cook, A. C. Tumor suppressor p53: analysis of wild-type and mutant p53 complexes. Mol. Cell Biol., 11: 12-19, 1991.
16. Yermilov, V., Rubio, J., and Ohshima, H. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett., 376: 207-210, 1995.
17. Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., and Shay, J. W. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell Biol., 12: 2866-2871, 1992.
18. Hainaut, P., and Milner, J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res., 53: 4469-4473, 1993.
19. Hainaut, P., Hall, A., and Milner, J. Analysis of p53 quaternary structure in relation to sequence-specific DNA binding. Oncogene, 9: 299-303, 1994.
20. Stephen, C. W., and Lane, D. P. Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library. J. Mol. Biol., 225: 577-583, 1992.
21. van der Vliet, A., Eiserich, J. P., O'Neill, C. A., Halliwell, B., and Cross, C. E. Tyrosine modification by reactive nitrogen species: a closer look. Arch. Biochem, Biophys., 319: 341-349, 1995.
22. Messmer, U. K., Ankarcrona, M., Nicotera, P., and Brune, B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett., 355: 23-26, 1994.
23. Wink, D. A., Cook, J. A., Pacelli, R., DeGraff, W., Gamson, J., Liebmann, J., Krishna, M. C., and Mitchell, J. B. The effect of various nitric oxide-donor agents on 4 hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection. Arch. Biochem. Biophys., 331: 241-248, 1996.
24. Boughton Smith, N. K., Evans, S. M., Hawkey, C. J., Cole, A. T., Balsitis, M., Whittle, B. J., and Moncada, S. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet, 342: 338-340, 1993.
25. Rachmilewitz, D., Stamler, J. S., Bachwich, D., Karmeli, F., Ackerman, Z., and Podolsky, D. K. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut, 36: 718-723, 1995.
26. Fehsel, K., Kroncke, K. D., Meyer, K. L., Huber, H., Wahn, V., and Kolb Bachofen, V. Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol., 155: 2858-2865, 1995.
27. Ho, Y-S., Wang, Y., and Lin, J-K. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol. Carcinog., 16: 20-31, 1996.
28. Gorsdorf, S., Appel, K. E., Engeholm, C., and Obe, G. Nitrogen dioxide induces DNA single-strand breaks in cultured Chinese hamster cells. Carcinogenesis (Lond.), 11: 37-41, 1990.
29. Wink, D. A., Kasprzak, K. S., Maragos, C. M., Elespuru, R. K., Misra, M., Dunams, T. M., Cebula, T. A., Koch, W. H., Andrews, A. W., Allen, J. S., and Keefer, L. K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science (Washington DC), 254: 1001-1003, 1991.
30. Marletta, M. A. Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. Chem. Res. Toxicol., 1: 249-257, 1988.
31. Rubio, J., Yermilov, V., and Ohshima, H. DNA damage induced by peroxynitrite: formation of 8-nitroguanine and base propenals. In: S. Moncada, J. Stamler, S. Gross, and E. A. Higg (eds.), The Biology of Nitric Oxide, Part 5. pp. 34. London: Portland Press, 1996.
32. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev., 8: 2540-2551, 1994.
33. Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R. G., and Moncada, S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72: 41-44, 1995.
34. Cobbs, C. S., Brenman, J. E., Aldape, K. D., Bredt, D. S., and Israel, M. A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res., 55: 727-730, 1995.
35. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
36. MacGeoch, C., Barnes, D. M., Newton, J. A., Mohammed, S., Hodgson, S. V., Ng, M., Bishop, D. T., and Spurr, N. K. p53 protein detected by immunohistochemical staining is not always mutant, Dis. Markers, 11: 239-250, 1993.
37. Midgley, C. A., Fisher, C. J., Bartek, J., Vojtesek, B., Lane, D., and Barnes, D. M. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J. Cell Sci., 101: 183-189, 1992.
38. Forrester, K., Ambs, S., Lupold, S. E., Kapust, R. B., Spillare, E. A., Weinberg, W. C., Felley-Bosco, E., Wang, X. W., Geller, D. A., Tzeng, E., Billiar, T. R., and Harris, C. C. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. USA, 93: 2442-2447, 1996.